The change of eosinophils in the perioperative period is significantly associated with the prognosis in patients with lung cancer

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Chansky K, Detterbeck FC, Nicholson AG et al. The IASLC Lung Cancer Staging Project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM Classification of Lung Cancer. J. Thorac. Oncol. 12(7), 1109–1121 (2017). • This may help explain why stage II patients are affected by peripheral blood eosinophil changes and those in stage I are not.
  MedlineGoogle Scholar
• 2. Carretero R, Sektioglu IM, Garbi N et al. Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(⁺) T cells. Nat. Immunol. 16(6), 609–617 (2015).
  Medline CASGoogle Scholar
• 3. Yang X, Wang L, Du H et al. Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy. Medicine 100(3), e24328 (2021).
  Medline CASGoogle Scholar
• 4. Davis BP, Rothenberg ME. Eosinophils and cancer. Cancer Immunol. Res. 2(1), 1–8 (2014).
  Medline CASGoogle Scholar
• 5. Adamko DJ, Odemuyiwa SO, Vethanayagam D et al. The rise of the phoenix: the expanding role of the eosinophil in health and disease. Allergy 60(1), 13–22 (2005).
  Medline CASGoogle Scholar
• 6. Kita H. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol. Rev. 242(1), 161–177 (2011).
  Medline CASGoogle Scholar
• 7. Munitz A, Levi-Schaffer F. Eosinophils: ‘new’ roles for ‘old’ cells. Allergy 59(3), 268–275 (2004).
  Medline CASGoogle Scholar
• 8. Simon SCS, Utikal J, Umansky V. Opposing roles of eosinophils in cancer. Cancer Immunol. Immunother. 68(5), 823–833 (2019).
  MedlineGoogle Scholar
• 9. Rakesh N, Devi Y, Majumdar K et al. Tumour associated tissue eosinophilia as a predictor of locoregional recurrence in oral squamous cell carcinoma. J. Clin. Exp. Dent. 7(1), e1–e6 (2015).
  MedlineGoogle Scholar
• 10. Sachs E, Sartipy U, Jackson V. Sex and survival after surgery for lung cancer: a Swedish nationwide cohort. Chest 159(5), 2029–2039 (2021).
  MedlineGoogle Scholar
• 11. Tang H, Liao Y, Xu L et al. Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice. Int. J. Cancer 133(10), 2473–2482 (2013). • This laid a theoretical foundation for the current study's gender-based grouping.
  Medline CASGoogle Scholar
• 12. Tang H, Liao Y, Chen G et al. Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-beta. Med. Oncol. 29(4), 2640–2648 (2012).
  Medline CASGoogle Scholar
• 13. Bai Y, Shen W, Zhang L et al. Oestrogen receptor beta5 and epidermal growth factor receptor synergistically promote lung cancer progression. Autoimmunity 51(4), 157–165 (2018).
  Medline CASGoogle Scholar
• 14. Ichinose Y, Kato H, Koike T et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J. Thorac. Cardiovasc. Surg. 122(4), 803–808 (2001). • This laid a theoretical foundation for the current study's lobe-based grouping.
  Medline CASGoogle Scholar
• 15. Watanabe S, Suzuki K, Asamura H. Superior and basal segment lung cancers in the lower lobe have different lymph node metastatic pathways and prognosis. Ann. Thorac. Surg. 85(3), 1026–1031 (2008).
  MedlineGoogle Scholar
• 16. Ettinger DS, Wood DE, Aisner DL et al. NCCN guidelines insights: non-small cell lung cancer, version 2.2021. JNCCN 19(3), 254–266 (2021).
  Medline CASGoogle Scholar
• 17. Zhang JT, Liu SY, Gao W et al. Longitudinal undetectable molecular residual disease defines potentially cured population in localized non-small cell lung cancer. Cancer Discov. doi:10.1158/2159-8290.CD-21-1486 OF1-OF12 (2022) (Epub ahead of print).
  Google Scholar
• 18. Xia L, Mei J, Kang R et al. Perioperative ctDNA-based molecular residual disease detection for non-small cell lung cancer: a prospective multicenter cohort study (LUNGCA-1). Clin. Cancer Res. doi:10.1158/1078-0432.CCR-21-3044 (2021) (Epub ahead of print).
  Google Scholar
• 19. Varricchi G, Galdiero MR, Loffredo S et al. Eosinophils: the unsung heroes in cancer? Oncoimmunology 7(2), e1393134 (2018).
  MedlineGoogle Scholar
• 20. Steel JL, Kim KH, Dew MA et al. Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory study. J. Pain Symptom Manage. 39(5), 859–871 (2010).
  MedlineGoogle Scholar
• 21. Cuschieri A, Talbot IC, Weeden S et al. Influence of pathological tumour variables on long-term survival in resectable gastric cancer. Br. J. Cancer 86(5), 674–679 (2002).
  Medline CASGoogle Scholar
• 22. Zhang Y, Ren H, Wang L et al. Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma. Int. J. Mol. Sci. 15(6), 9718–9734 (2014).
  Medline CASGoogle Scholar
• 23. Riquet M, Rivera C, Pricopi C et al. Is the lymphatic drainage of lung cancer lobe-specific? A surgical appraisal. Eur. J. Cardiothorac. Surg. 47(3), 543–549 (2015). •• This may help explain why patients with tumors in the right lobe are affected by peripheral blood eosinophil changes and those in the left lobe are not.
  MedlineGoogle Scholar
• 24. Zhao Y, Mao Y, He J et al. Lobe-specific lymph node dissection in clinical stage IA solid-dominant non-small-cell lung cancer: a propensity score matching study. Clin. Lung Cancer 22(2), e201–e210 (2021). •• This may help explain why patients with tumors in the right lobe are affected by peripheral blood eosinophil changes and those in the left lobe are not.
  MedlineGoogle Scholar
• 25. Rothenberg ME. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Am. J. Respir. Cell Mol. Biol. 21(3), 291–295 (1999).
  Medline CASGoogle Scholar
• 26. Shi HZ, Humbles A, Gerard C et al. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J. Clin. Invest. 105(7), 945–953 (2000).
  Medline CASGoogle Scholar
• 27. Friend DS, Gurish MF, Austen KF et al. Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection. J. Immunol. 165(1), 344–352 (2000).
  Medline CASGoogle Scholar
• 28. Oliveira DT, Biassi TP, Faustino SE et al. Eosinophils may predict occult lymph node metastasis in early oral cancer. Clin. Oral Investig. 16(6), 1523–1528 (2012).
  Medline CASGoogle Scholar
• 29. Geiger H, De Haan G, Florian MC. The ageing haematopoietic stem cell compartment. Nat. Rev. Immunol. 13(5), 376–389 (2013). • This may help explain why patients younger than 60 years old are affected by peripheral blood eosinophil changes and those older than 60 are not.
  Medline CASGoogle Scholar
• 30. Oh J, Lee YD, Wagers AJ. Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat. Med. 20(8), 870–880 (2014).
  Medline CASGoogle Scholar
• 31. Conboy IM, Conboy MJ, Wagers AJ et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433(7027), 760–764 (2005). • This may help explain why patients younger than 60 years old are affected by peripheral blood eosinophil changes and those older than 60 are not.
  Medline CASGoogle Scholar
• 32. Riether C, Schurch CM, Ochsenbein AF. Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ. 22(2), 187–198 (2015).
  Medline CASGoogle Scholar
• 33. Pioli PD, Casero D, Montecino-Rodriguez E et al. Plasma cells are obligate effectors of enhanced myelopoiesis in aging bone marrow. Immunity 51(2), 351–366 e356 (2019).
  Medline CASGoogle Scholar
• 34. Brigger D, Riether C, Van Brummelen R et al. Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age. Nat. Metab. 2(8), 688–702 (2020).
  Medline CASGoogle Scholar
• 35. Siroux V, Curt F, Oryszczyn MP et al. Role of gender and hormone-related events on IgE, atopy, and eosinophils in the epidemiological study on the genetics and environment of asthma, bronchial hyperresponsiveness and atopy. J. Allergy Clin. Immunol. 114(3), 491–498 (2004).
  MedlineGoogle Scholar